347 related articles for article (PubMed ID: 21736953)
1. Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism.
Albers JJ; Vuletic S; Cheung MC
Biochim Biophys Acta; 2012 Mar; 1821(3):345-57. PubMed ID: 21736953
[TBL] [Abstract][Full Text] [Related]
2. Roles of plasma lipid transfer proteins in reverse cholesterol transport.
Yamashita S; Sakai N; Hirano K; Ishigami M; Maruyama T; Nakajima N; Matsuzawa Y
Front Biosci; 2001 Mar; 6():D366-87. PubMed ID: 11229884
[TBL] [Abstract][Full Text] [Related]
3. The Role of Phospholipid Transfer Protein in the Development of Atherosclerosis.
Jiang XC; Yu Y
Curr Atheroscler Rep; 2021 Jan; 23(3):9. PubMed ID: 33496859
[TBL] [Abstract][Full Text] [Related]
4. Plasma lipid transfer proteins: The role of PLTP and CETP in atherogenesis.
Chowaniec Z; Skoczyńska A
Adv Clin Exp Med; 2018 Mar; 27(3):429-436. PubMed ID: 29558025
[TBL] [Abstract][Full Text] [Related]
5. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes.
Jiang X; Francone OL; Bruce C; Milne R; Mar J; Walsh A; Breslow JL; Tall AR
J Clin Invest; 1996 Nov; 98(10):2373-80. PubMed ID: 8941656
[TBL] [Abstract][Full Text] [Related]
6. Transgenic mice expressing human phospholipid transfer protein have increased HDL/non-HDL cholesterol ratio.
Albers JJ; Tu AY; Paigen B; Chen H; Cheung MC; Marcovina SM
Int J Clin Lab Res; 1996; 26(4):262-7. PubMed ID: 9007618
[TBL] [Abstract][Full Text] [Related]
7. Adipocyte phospholipid transfer protein and lipoprotein metabolism.
Jiang H; Yazdanyar A; Lou B; Chen Y; Zhao X; Li R; Hoang Bui H; Kuo MS; Navab M; Qin S; Li Z; Jin W; Jiang XC
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):316-22. PubMed ID: 25477345
[TBL] [Abstract][Full Text] [Related]
8. New therapeutic horizons for plasma phospholipid transfer protein (PLTP): Targeting endotoxemia, infection and sepsis.
Gautier T; Deckert V; Nguyen M; Desrumaux C; Masson D; Lagrost L
Pharmacol Ther; 2022 Aug; 236():108105. PubMed ID: 34974028
[TBL] [Abstract][Full Text] [Related]
9. Phospholipid transfer protein interacts with and stabilizes ATP-binding cassette transporter A1 and enhances cholesterol efflux from cells.
Oram JF; Wolfbauer G; Vaughan AM; Tang C; Albers JJ
J Biol Chem; 2003 Dec; 278(52):52379-85. PubMed ID: 14559902
[TBL] [Abstract][Full Text] [Related]
10. The effect of phospholipid transfer protein on lipoprotein metabolism and atherosclerosis.
Jiang XC
Front Biosci; 2002 Jul; 7():d1634-41. PubMed ID: 12086920
[TBL] [Abstract][Full Text] [Related]
11. Inducible expression of phospholipid transfer protein (PLTP) in transgenic mice: acute effects of PLTP on lipoprotein metabolism.
Moerland M; Anghelescu N; Samyn H; van Haperen R; van Gent T; Strouboulis J; van Tol A; Grosveld F; de Crom R
Transgenic Res; 2007 Aug; 16(4):503-13. PubMed ID: 17437182
[TBL] [Abstract][Full Text] [Related]
12. Determination of human plasma phospholipid transfer protein mass and activity.
Jauhiainen M; Ehnholm C
Methods; 2005 Jun; 36(2):97-101. PubMed ID: 15893933
[TBL] [Abstract][Full Text] [Related]
13. Acute elevation of plasma PLTP activity strongly increases pre-existing atherosclerosis.
Moerland M; Samyn H; van Gent T; van Haperen R; Dallinga-Thie G; Grosveld F; van Tol A; de Crom R
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1277-82. PubMed ID: 18421000
[TBL] [Abstract][Full Text] [Related]
14. Sex differences in atherosclerosis in mice with elevated phospholipid transfer protein activity are related to decreased plasma high density lipoproteins and not to increased production of triglycerides.
Lie J; Moerland M; van Gent T; van Haperen R; Scheek L; Sadeghi-Niaraki F; de Crom R; van Tol A
Biochim Biophys Acta; 2006 Sep; 1761(9):1070-7. PubMed ID: 16935026
[TBL] [Abstract][Full Text] [Related]
15. Plasma phospholipid transfer activity is essential for increased atherogenesis in PLTP transgenic mice: a mutation-inactivation study.
Samyn H; Moerland M; van Gent T; van Haperen R; Metso J; Grosveld F; Jauhiainen M; van Tol A; de Crom R
J Lipid Res; 2008 Dec; 49(12):2504-12. PubMed ID: 18711210
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation at the phospholipid transfer protein locus affects its activity and high-density lipoprotein size and is a novel marker of cardiovascular disease susceptibility.
Vergeer M; Boekholdt SM; Sandhu MS; Ricketts SL; Wareham NJ; Brown MJ; de Faire U; Leander K; Gigante B; Kavousi M; Hofman A; Uitterlinden AG; van Duijn CM; Witteman JC; Jukema JW; Schadt EE; van der Schoot E; Kastelein JJ; Khaw KT; Dullaart RP; van Tol A; Trip MD; Dallinga-Thie GM
Circulation; 2010 Aug; 122(5):470-7. PubMed ID: 20644014
[TBL] [Abstract][Full Text] [Related]
17. Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus.
de Vries R; Dallinga-Thie GM; Smit AJ; Wolffenbuttel BH; van Tol A; Dullaart RP
Diabetologia; 2006 Feb; 49(2):398-404. PubMed ID: 16374627
[TBL] [Abstract][Full Text] [Related]
18. Phospholipid transfer protein: its impact on lipoprotein homeostasis and atherosclerosis.
Jiang XC
J Lipid Res; 2018 May; 59(5):764-771. PubMed ID: 29438986
[TBL] [Abstract][Full Text] [Related]
19. Human plasma phospholipid transfer protein specific activity is correlated with HDL size: implications for lipoprotein physiology.
Cheung MC; Wolfbauer G; Deguchi H; Fernández JA; Griffin JH; Albers JJ
Biochim Biophys Acta; 2009 Mar; 1791(3):206-11. PubMed ID: 19162221
[TBL] [Abstract][Full Text] [Related]
20. Overexpression and deletion of phospholipid transfer protein reduce HDL mass and cholesterol efflux capacity but not macrophage reverse cholesterol transport.
Kuwano T; Bi X; Cipollari E; Yasuda T; Lagor WR; Szapary HJ; Tohyama J; Millar JS; Billheimer JT; Lyssenko NN; Rader DJ
J Lipid Res; 2017 Apr; 58(4):731-741. PubMed ID: 28137768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
